Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon

NCT01333735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2015-09-04

No results posted yet for this study

Summary

The aim of the study is to investigate the impact of adjuvant chemotherapy on cognitive function in patients aged over 65 and suffering from breast cancer or colon.

Conditions

Sponsors & Collaborators

  • National Cancer Institute, France

    collaborator OTHER_GOV
  • Sanofi

    collaborator INDUSTRY
  • Centre Francois Baclesse

    lead OTHER

Principal Investigators

  • Florence JOLY-LOBBEDEZ, PD · Centre François Baclesse

Eligibility

Min Age
66 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333735 on ClinicalTrials.gov